On June 5, South Africa will begin one of its most important HIV prevention drives in decades.
The country will start to roll out an HIV prevention injection that has to be taken only twice a year.
But new medicines alone do not stop epidemics. Health systems, political choices and funding determine whether the medication reaches the people who need it.
That is the contradiction policymakers now face: just as one of the most powerful HIV prevention tools becomes available, many of the programmes needed to deliver it have been weakened by funding cuts and political changes.
Will South Africas launch become more than a symbolic event that shows what serious HIV prevention leadership looks like at a time when donor funding is shrinking and global uncertainty is growing?
Intodays newsletter,Mia Malan explains why lenacapavir is the jab SA cant afford to waste.Sign up for our newsletter today.
COMMENT
South Africa is about to begin one of the most important HIV prevention drives in decades.
